Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)

计划入组 30 人 · 首次发布于 2008 年 6 月 2 日

CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load

计划入组 40 人 · 首次发布于 2013 年 8 月 16 日

NDPH Biomarker Study in Children and Adolescents

计划入组 38 人 · 首次发布于 2023 年 8 月 30 日

CGRP antagonist

Calcitonin gene-related peptide

STI-B150X

KalVista Pharmaceuticals

United States

Exelixis, Inc.

United States

Cytokinetics, Incorporated

United States

Migraine Treatment Advances: CGRP Inhibitors, Digital Therapeutics, and Novel Compounds Highlight 2024

Slate Medicines Raises $130M to Develop Novel PACAP-Targeting Migraine Drug

FDA Rejects Satsuma's STS101 Nasal Migraine Treatment Citing Manufacturing Issues